부산대학교 도서관

In conclusion, the low prevalence of hydrocortisone 21-acetate allergy is very far from justifying its inclusion in the baseline series, even if in selected patients it is mandatory to patch test this CS to avoid false negative results. Keywords: corticosteroids; hydrocortisone 21-acetate; patch test; SIDAPA baseline series EN corticosteroids hydrocortisone 21-acetate patch test SIDAPA baseline series 217 219 3 02/24/22 20220301 NES 220301 Corticosteroids (CSs) are well-known contact sensitizers that induce allergic contact dermatitis, with a prevalence up to 5%.1 Among CSs, budesonide is the strongest contact sensitizer and the allergy prevalence to this CS was recently assessed to be 0.6% in Italy, confirming a decreasing trend of contact allergy to CSs during the last decade. This is probably due to the use of "safer" CSs with regard their contact sensitization potential.2 On the other hand, little is known about the potential sensitizing properties of hydrocortisone 21-acetate, a topical CS widely used in many over-the-counter preparations in Italy.3 We investigated the prevalence contact allergy to hydrocortisone 21-acetate in consecutive patients. [Extracted from the article]